Literature DB >> 62839

Ectopic and eutopic secretion of chorionic gonadotropin and its sub-nits in vitro: comparison of clonal strains from carcinomas of lung and placenta.

J M Lieblich, B D Weintraub, G H Krauth, P O Kohler, A S Rabson, S W Rosen.   

Abstract

We compared rates of secretion in vitro of human chorionic gonadotropin (HCG) and its subunits alpha and beta by established clonal cell lines of a bronchogenic carcinoma (ChaGo) and a choriocarcinoma (JEG). Clones showing the highest secretion rates of either HCG or its subunits were studied: ChaGo-K1, a new clonal strain, and ChaGo-C5 and JEG-3, two previously reported clonal lines. Cells were grown under identical conditions in the same laboratory. Hormone and subunit concentrations were measured by radioimmunoassays. ChaGo-K1 and ChaGo-C5 secreted only alpha-subunit whereas JEG-3 secreted only HCG. Average peak secretion rates in picomoles/day/mg protein were: for ChaGo-K1, HCG less than 0.3, alpha=290, and beta less than 0.5; for ChaGo-C5, HCG less than 0.3, alpha=21, and beta less than 0.5; and for JEG-3, HCG=18, alpha less than 0.7, and beta less than 0.5. The ChaGo-K1 secretion rate of alpha was greater than that of any of out previously reported ChaGo clones. Significant quantities of estradiol and progesterone accumulated in the media of all three cell lines; however, only JEG-3 secreted detectable quantities of placental lactogen. Thus under identical culture conditions, a bronchogenic carcinoma clonal line secreted only alpha-subunit, whereas a choriocarcinoma line secreted only HCG; these findings implied major differences in cellular control mechanisms. Moreover, the ectopic secretions of alpha exceeded the eutopic trophoblastic secretion of HCG, which suggested that in certain cases ectopic protein production may be even more efficient than nonectopic production.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 62839     DOI: 10.1093/jnci/56.5.911

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  9 in total

1.  Regulation of alkaline phosphatase expression in human choriocarcinoma cell lines.

Authors:  T A Hamilton; A W Tin; H H Sussman
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

Review 2.  Cell differentiation and the biological significance of inappropriate tumour products.

Authors:  M L Ellison
Journal:  Proc R Soc Med       Date:  1977-12

3.  Ectopic production in serum-free media of the common alpha subunit of the glycoprotein hormones.

Authors:  J S Morrow; B C Weintraub; S W Rosen
Journal:  In Vitro       Date:  1981-05

4.  Predominance of gonadotropin alpha-subunit resulting from preferential loss of hCG beta production in an established cell line.

Authors:  R O Hussa; R A Pattillo
Journal:  In Vitro       Date:  1980-07

5.  Molecular regulation of human placental growth factor (PlGF) gene expression in placental villi and trophoblast cells is mediated via the protein kinase a pathway.

Authors:  Christophe Depoix; Meng Kian Tee; Robert N Taylor
Journal:  Reprod Sci       Date:  2010-12-06       Impact factor: 3.060

6.  Sodium butyrate-induced alteration of growth properties and glycogen levels in cultured human colon carcinoma cells.

Authors:  D L Dexter; R Lev; G R McKendall; P Mitchell; P Calabres
Journal:  Histochem J       Date:  1984-02

7.  Human lung small-cell carcinoma contains bombesin.

Authors:  M D Erisman; R I Linnoila; O Hernandez; R P DiAugustine; L H Lazarus
Journal:  Proc Natl Acad Sci U S A       Date:  1982-04       Impact factor: 11.205

8.  A pulmonary large cell carcinoma cell line expressing neuroendocrine cell markers and human chorionic gonadotropin alpha-subunit.

Authors:  K Kasai; T Kameya; K Kadoya; C Wada
Journal:  Jpn J Cancer Res       Date:  1991-01

9.  Placental lactogen is expressed but is not translated into protein in breast cancer.

Authors:  Traci R Tuttle; Eric R Hugo; Wilson S Tong; Nira Ben-Jonathan
Journal:  PLoS One       Date:  2014-01-24       Impact factor: 3.240

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.